News

The latest news from the Swiss NASH Foundation. In a joint effort to tackle the increasing prevalence and burden of NASH, scientific experts and the leading pharmaceutical companies have joined forces, read all out their latest research, findings and events.

02 October 2019

Launched October 2019

The Swiss NASH Foundation was launched in October 2019, in Bern, Switzerland.

Read in full >

SWISSNASH_FDNFollow

Retweet on Twitter SWISSNASH_FDN Retweeted

Rohit Loomba @DrLoomba·

14 Oct

Multicenter Validation of Association Between Decline in MRI‐PDFF and histologic response https://wiley.altmetric.com/details/74396551

Retweet on Twitter SWISSNASH_FDN Retweeted

DrAlexandra @DrAlexaGastro·

13 Oct

Dr @dufour_jf presenting Treatment of #NASH: What is in the pipeline, session Fatty liver disease: What’s new in 2020 #UEGWeek @my_ueg

SWISSNASH_FDN @swissnash·

13 Oct

Inventiva receives FDA Breakthrough Therapy designation for lead drug candidate lanifibranor in NASH https://bit.ly/2GMCTIS @Duke_liverdoc @DrLoomba @NoureddinMD

Retweet on Twitter SWISSNASH_FDN Retweeted

The Lancet Gastroenterology & Hepatology @LancetGastroHep·

6 Oct

New Viewpoint - Shiha et al - Redefining fatty liver disease: an international patient perspective

https://www.thelancet.com/journals/langas/article/PIIS2468-1253(20)30294-6/fulltext

#NAFLD #MAFLD #fattyliver #livertwitter @EuropeLiver @Hep_Alliance @asscatinforma @ECPObesity